吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jun 1 2022

Full Issue

Perspectives: High Drug Prices Harm Those Who Need Prescriptions To Survive

Read recent commentaries about drug-cost issues.

July 2022 will mark a decade of availability of preexposure prophylaxis (PrEP), the use of antiretroviral medications to prevent HIV infection, yet less than a quarter of the 1.2 million people in the United States who could benefit from PrEP are taking it (see map). What went wrong? (Julia L. Marcus, Ph.D., M.P.H., Amy Killelea J.D., and Douglas S. Krakower, M.D., 5/28)

One morning last year, I woke up to a slight pain in my left eye. Over the next couple days, my vision blurred, and I lost the ability to see color in that eye. After a whirlwind afternoon of seeing my doctor, being rushed to an ophthalmologist, and then sent to the Tallahassee Memorial Healthcare emergency room for an MRI 鈥 I learned I have multiple sclerosis (MS).聽(Samantha Cooksey Strickland, 5/29)

The White House has consistently tried to do too many things at once (e.g., Biden鈥檚 overstuffed Build Back Better bill, a 鈥淯nity Agenda,鈥 etc.). In the lead-up to the midterms, Biden should limit his agenda to a short list of inflation-fighting measures (including a prescription drug cost-containment bill and energy bill to bring down fuel prices), a crime bill (including popular gun-safety measures) and a populist agenda targeting corporate irresponsibility. (Jennifer Rubin, 5/31)

The writer P.J. O鈥橰ourke said, 鈥淚f you think health care is expensive now, wait until you see what it costs when it鈥檚 free.鈥澛燩oliticians claim we have high health care costs and prescription drug prices, then imply that government price controls would lower costs. Some politicians have hopped on the price controls train.聽The fact is, that government price controls do far more harm than good. Nor are government price controls conservative ideas.聽(James Edwards, 5/30)

Over the past decade, a superpower has quietly invaded a peaceful country and killed hundreds of thousands of its citizens. The superpower isn鈥檛 Russia, and the victims aren鈥檛 Ukrainians. The weapons of war aren鈥檛 conventional weapons, they鈥檙e chemical weapons. The culprit is China, and the death toll is that of our fellow Americans. The United States has been flooded with synthetic fentanyl and other opioids from China. The Centers for Disease Control and Prevention reported last week that 71,200 Americans died of overdoses of these drugs in 2021. (Morgan Ortagus, 5/31)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF